The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 01, 2015

Filed:

May. 19, 2011
Applicants:

Timothy Cardozo, New York, NY (US);

Hong Wang, New York, NY (US);

David Ron, New York, NY (US);

Inventors:

Timothy Cardozo, New York, NY (US);

Hong Wang, New York, NY (US);

David Ron, New York, NY (US);

Assignee:

New York University, New York, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 49/00 (2006.01); A61K 31/225 (2006.01); A61K 31/24 (2006.01); A61K 31/4166 (2006.01); A61K 31/4245 (2006.01); A61K 31/428 (2006.01); A61K 31/433 (2006.01); A61K 31/496 (2006.01); A61K 31/519 (2006.01); A61K 31/536 (2006.01); C07D 207/416 (2006.01); C07D 239/42 (2006.01); C07D 249/12 (2006.01); C07D 265/22 (2006.01); C07D 277/44 (2006.01); C07D 277/54 (2006.01); C07D 277/66 (2006.01); C07D 307/54 (2006.01); C07D 317/60 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 403/12 (2006.01); C07D 409/12 (2006.01); C07D 417/14 (2006.01); C07D 487/04 (2006.01); C12Q 1/48 (2006.01); G06F 19/00 (2011.01); G06F 19/16 (2011.01);
U.S. Cl.
CPC ...
A61K 31/225 (2013.01); A61K 31/24 (2013.01); A61K 31/4166 (2013.01); A61K 31/428 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/496 (2013.01); A61K 31/519 (2013.01); A61K 31/536 (2013.01); C07D 207/416 (2013.01); C07D 239/42 (2013.01); C07D 249/12 (2013.01); C07D 265/22 (2013.01); C07D 277/44 (2013.01); C07D 277/54 (2013.01); C07D 277/66 (2013.01); C07D 307/54 (2013.01); C07D 317/60 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 403/12 (2013.01); C07D 409/12 (2013.01); C07D 417/14 (2013.01); C07D 487/04 (2013.01); C12Q 1/485 (2013.01); G06F 19/706 (2013.01); G06F 19/16 (2013.01);
Abstract

The present invention relates to a method of identifying compounds useful in inhibiting protein kinase-like endoplasmic reticulum protein kinase (PERK). The method comprises providing a first model comprising PERK active domains, where the said active domains are selected from the group consisting of the peptide spanning from amino acid residue Asp144 to amino acid residue Ser191 of SEQ ID NO: 1 and a peptide comprising the amino acid residue at position 7 of SEQ ID NO: 1, providing one or more candidate compounds, evaluating contact between the candidate compounds and the first model to determine which of the one or more candidate compounds have an ability to bind to and/or fit in the first model, and identifying the compounds which, based on said evaluating, have the ability to bind to and/or fit in the first model as compounds potentially useful for inhibiting PERK. The present invention further relates to compounds that can be used for inhibition of PERK, for example human PERK, and methods related to treatment of PERK-mediated diseases.


Find Patent Forward Citations

Loading…